Equities
  • Price (EUR)173.65
  • Today's Change0.05 / 0.03%
  • Shares traded0.00
  • 1 Year change+37.06%
  • Beta--
Data delayed at least 15 minutes, as of Sep 24 2021.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

McKesson Corporation is focused distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The Company’s segments include U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. The International segment provides distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. RxTS segment combines its technologies, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, to serve its biopharma and life sciences partners and patients.

  • Revenue in USD (TTM)245.22bn
  • Net income in USD-4.49bn
  • Incorporated1994
  • Employees59.00k
  • Location
    Mckesson Corp6555 State Highway 161IRVING 75039-2402United StatesUSA
  • Phone+1 (972) 446-4800
  • Fax+1 (302) 636-5454
  • Websitehttp://www.mckesson.com
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image